Effect of combined administration of amino-binding substances in hepatic encephalopathy.
D001120:Arginine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005971:Glutamates / Q000627:therapeutic use*; D006501:Hepatic Encephalopathy / Q000628:therapy*; D006801:Humans
D005971:Glutamates; D001120:Arginine
ARGININE/therapeutic use; GLUTAMATES/therapeutic use; HEPATIC COMA/therapy